Cellosaurus logo
expasy logo

Cellosaurus YSCCC-G100 (CVCL_QZ47)

[Text version]
Cell line name YSCCC-G100
Accession CVCL_QZ47
Resource Identification Initiative To cite this cell line use: YSCCC-G100 (RRID:CVCL_QZ47)
Comments Population: Japanese.
Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
Disease Cholangiocarcinoma (NCIt: C4436)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_3629 (YSCCC)
Sex of cell Female
Age at sampling 70Y
Category Cancer cell line
Publications

PubMed=21451941; DOI=10.1007/s00534-011-0376-7
Sato J., Kimura T., Saito T., Anazawa T., Kenjo A., Sato Y., Tsuchiya T., Gotoh M.
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
J. Hepatobiliary Pancreat. Sci. 18:700-711(2011)

Cross-references
Cell line databases/resources Cell_Model_Passport; SIDM01929
Encyclopedic resources Wikidata; Q54995522
Entry history
Entry creation05-Mar-2018
Last entry update29-Jun-2023
Version number7